Abiopharma

Evommune Announces Top-line Results from EVO756 Phase 2b Trial in Moderate-to-Severe Chronic Spontaneous Urticaria

Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis

Crane Company Announces Date for Second Quarter 2026 Earnings Release and Teleconference

Alto Ingredients, Inc. Added to Russell 2000® and Russell 3000® Indexes

Patriot Bank Opens Flagship California Location in Beverly Hills With Over $100 Million in Deposits

RXO Wins Prestigious “Best in Cargo Security” Award from CargoNet

WeShop Added to Russell 3000® and Russell Microcap® Indexes

Innovative Aerosystems to Join U.S. Small-Cap Russell 2000® Index

Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress

Marti Technologies Provides Update on Its Share Repurchase Program